The NASDAQ 100 Pre-Market Indicator is up 12.73 to 2,741.27. The total Pre-Market volume is currently 6,487,024 shares traded. The following are the most active stocks for the pre-market
KYTHERA Biopharmaceuticals, which is commercializing an injectable treatment for double chins with Bayer, raised $70 million by offering 4.4 million shares at $16, at high end of the range
The following companies are expected to report earnings prior to market open on 10/11/2012. Visit our Earnings Calendar for a full list of expected earnings releases.